Skip to main content

Medical Services

Clinical Challenges
Johns Hopkins Medicine announced that it is collaborating with 14 other Maryland hospitals on a five-year initiative aimed at reducing the use of emergency departments and police for substance use and mental health crises.
Medical Services
A Yale study of 400 clinicians found that just 21% of emergency department clinicians say they are prepared to prescribe buprenorphine for the treatment of opioid use disorder.
Medical Services
A long-term safety study of extended-release buprenorphine illustrates a safety profile comparable to that of the sublingual version of the drug.
Medical Services
A virtual Rx Drug Abuse & Heroin Summit session addressed the often overlooked topic of community pharmacists' role in facilitating or blocking access to treatment for opioid use disorder.
Medical Services
Both internal and external considerations are moving more local corrections systems toward maintaining evidence-based care for opioid use disorder.
Medical Services
A longer duration of treatment with the injectable formulation of buprenorphine for opioid use disorder was associated with more favorable abstinence outcomes in a newly published study.
Coronavirus
Public health risk is forcing addiction treatment programs to rethink their typical approaches to patient drug testing at this time.
Medical Services
Nineteen projects to improve access to treatment have received funding in a Foundation for Opioid Response Efforts round that attracted nearly 450 proposals.
Medical Services
A major update to the American Society of Addiction Medicine's practice guideline for treating opioid use disorder includes the advice that unavailability or refusal of psychosocial treatment should not impede patient access to medication.
Medical Services
Overcoming stigma and cultivating a strong care team are among the components identified in Altarum's discussions with providers on addressing barriers to medication treatment for opioid use disorder.
Medical Services
An analysis of a state's publicly funded treatment for opioid use disorder found a substantially lower overdose death risk for patients receiving medication treatment, with risk for all patients increasing post-treatment.
Back to Top